Latest News about JNJ
Recent news which mentions JNJ
3 Best Buffett Stocks to Buy for the Long Haul
December 24, 2021
From Motley Fool
From Benzinga
3 Healthcare Stocks to Buy If You're Worried About a Market Crash
December 21, 2021
From Motley Fool
From Benzinga
This Cardiac Device Could Possibly Be the Game Changer That Saves Millions of Lives
December 21, 2021
From Benzinga
3 Things About Novavax That Smart Investors Know
December 21, 2021
From Motley Fool
What Are the Best Vaccine Stocks to Own in 2022?
December 21, 2021
From Motley Fool
Should you cancel your Christmas trip because of omicron? Here are 5 steps to stay healthy during the holidays
December 21, 2021
From MarketWatch
Data suggests boosters essential to avoid omicron infection, and Fauci says best way to protect kids is make sure adults around them are fully vaccinated
December 20, 2021
From MarketWatch
Dr. Francis Collins, National Institutes of Health outgoing director: ‘Nobody was expecting omicron. This one really was a curveball.’
December 20, 2021
From MarketWatch
Stocks vs. Bonds and the 60/40 Rule
December 18, 2021
From Motley Fool
Why Pfizer and Johnson & Johnson Fell on Friday
December 17, 2021
From Motley Fool
The Week In Cannabis: Pfizer, Visa, $730M+ In Financings, Malta, EU, Columbia Care, MedMen, Uruguay And More
December 17, 2021
From Benzinga
Reddit asks, ‘What’s surprised you the most about the pandemic?’ Here’s the most popular responses
December 17, 2021
From MarketWatch
Unvaccinated Americans facing ‘winter of severe illness and death,’ Biden warns, as omicron starts to spread across the U.S.
December 17, 2021
From MarketWatch
Benzinga's Top Ratings Upgrades, Downgrades For December 17, 2021
December 17, 2021
From Benzinga
Investors Dump Tech Stocks in Favor of Value Stocks
December 17, 2021
From Benzinga
CDC Backs mRNA COVID-19 Vaccines Over Johnson & Johnson's, Citing Higher Rates Of Clotting Cases: Report
December 17, 2021
From Benzinga
Johnson & Johnson's, Sputnik, Sinopharm COVID-19 Vaccines Show Weakness Against Omicron Variant: Study
December 17, 2021
From Benzinga
Why Moderna and Pfizer Beat the Market Today
December 16, 2021
From Motley Fool
Unstoppable Dividend King for 2022: AbbVie or Johnson & Johnson?
December 16, 2021
From Motley Fool
EU meets to discuss response to omicron variant as France restricts travel from UK, and CDC panel to discuss rare side effect from J&J vaccine
December 16, 2021
From MarketWatch
3 Consumer Staples Stocks to Buy for Safety
December 15, 2021
From InvestorPlace
From Benzinga
Sanofi, Glaxo's COVID-19 Vaccine Candidate Works As Booster, But Data Readout Pushed Back
December 15, 2021
From Benzinga
Omicron variant remains a ‘very high’ risk as it spreads fast and shows resistance to vaccines, but WHO says more data needed to know if it’s more lethal
December 15, 2021
From MarketWatch
From MarketWatch
10 Stocks to Buy if You Have $5,000 in Starter Money
December 14, 2021
From InvestorPlace
Investing in an Alternative Asset Like an NFT? This Company Says It May Have Better Options
December 14, 2021
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.